Celltrion Pharm, Inc. 068760.KQ Stock
Celltrion Pharm, Inc. Price Chart
Celltrion Pharm, Inc. 068760.KQ Financial and Trading Overview
| Celltrion Pharm, Inc. stock price | 94300 KRW |
| Previous Close | 82400 KRW |
| Open | 82700 KRW |
| Bid | 83200 KRW x 0 |
| Ask | 83300 KRW x 0 |
| Day's Range | 82100 - 84800 KRW |
| 52 Week Range | 56200 - 101200 KRW |
| Volume | 163.63K KRW |
| Avg. Volume | 432.54K KRW |
| Market Cap | 2.83T KRW |
| Beta (5Y Monthly) | 0.310626 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
068760.KQ Valuation Measures
| Enterprise Value | 3.59T KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.312531 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 13.056 |
| Enterprise Value/EBITDA | 83.812 |
Trading Information
Celltrion Pharm, Inc. Stock Price History
| Beta (5Y Monthly) | 0.310626 |
| 52-Week Change | 16.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 101200 KRW |
| 52 Week Low | 56200 KRW |
| 50-Day Moving Average | 84834 KRW |
| 200-Day Moving Average | 71492.62 KRW |
068760.KQ Share Statistics
| Avg. Volume (3 month) | 432.54K KRW |
| Avg. Daily Volume (10-Days) | 147.23K KRW |
| Shares Outstanding | 34.05M |
| Float | 17.6M |
| Short Ratio | N/A |
| % Held by Insiders | 52.62% |
| % Held by Institutions | 6.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.05:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2020 |
| Most Recent Quarter (mrq) | March 31, 2021 |
| Next Fiscal Year End | December 31, 2021 |
Profitability
| Profit Margin | 9.47% |
| Operating Margin (ttm) | 10.51% |
| Gross Margin | 29.42% |
| EBITDA Margin | 15.57% |
Management Effectiveness
| Return on Assets (ttm) | 3.40% |
| Return on Equity (ttm) | 8.91% |
Income Statement
| Revenue (ttm) | 274.73B KRW |
| Revenue Per Share (ttm) | 6962.84 KRW |
| Quarterly Revenue Growth (yoy) | 92.70% |
| Gross Profit (ttm) | 72.93B KRW |
| EBITDA | 42.8B KRW |
| Net Income Avi to Common (ttm) | 26.03B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 228.39% |
Balance Sheet
| Total Cash (mrq) | 34.63B KRW |
| Total Cash Per Share (mrq) | 878.38 KRW |
| Total Debt (mrq) | 191.75B KRW |
| Total Debt/Equity (mrq) | 63.34 KRW |
| Current Ratio (mrq) | 1.235 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 28.44B KRW |
| Levered Free Cash Flow (ttm) | -20097181696 KRW |
Profile of Celltrion Pharm, Inc.
| Country | South Korea |
| State | N/A |
| City | Cheongju |
| Address | 82, 2sandan-ro |
| ZIP | N/A |
| Phone | 82 4 3717 7000 |
| Website | https://www.celltrionph.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.
Q&A For Celltrion Pharm, Inc. Stock
What is a current 068760.KQ stock price?
Celltrion Pharm, Inc. 068760.KQ stock price today per share is 94300 KRW.
How to purchase Celltrion Pharm, Inc. stock?
You can buy 068760.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Celltrion Pharm, Inc.?
The stock symbol or ticker of Celltrion Pharm, Inc. is 068760.KQ.
How many shares does Celltrion Pharm, Inc. have in circulation?
The max supply of Celltrion Pharm, Inc. shares is 41.42M.
What is Celltrion Pharm, Inc. Price to Earnings Ratio (PE Ratio)?
Celltrion Pharm, Inc. PE Ratio is now.
What was Celltrion Pharm, Inc. earnings per share over the trailing 12 months (TTM)?
Celltrion Pharm, Inc. EPS is 0 KRW over the trailing 12 months.